(Total Views: 91)
Posted On: 04/01/2021 9:12:47 AM
Post# of 107196

$CURR News : CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline
https://www.barchart.com/story/news/1365570/c...l-pipeline

